Meso-Butestrol

From WikiMD's WELLNESSPEDIA

meso-butestrol.png

Meso-Butestrol is a synthetic, nonsteroidal estrogen of the stilbestrol group. It is a derivative of diethylstilbestrol (DES), which was widely used in the mid-20th century for various medical conditions. Meso-Butestrol has been studied for its estrogenic properties and potential applications in hormone replacement therapy and other medical treatments.

Chemical Structure and Properties[edit]

Meso-Butestrol is chemically related to diethylstilbestrol and shares a similar structure. It is a member of the stilbestrol family, which are compounds characterized by their two phenyl rings connected by a double bond. The chemical structure of Meso-Butestrol allows it to bind to estrogen receptors in the body, mimicking the effects of natural estrogens.

Medical Uses[edit]

Meso-Butestrol has been investigated for its potential use in hormone replacement therapy (HRT) for postmenopausal women. Like other estrogens, it can help alleviate symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. However, due to concerns about the safety and side effects of synthetic estrogens, its use has been limited.

Side Effects and Risks[edit]

The use of synthetic estrogens, including Meso-Butestrol, has been associated with various side effects and health risks. These may include an increased risk of breast cancer, endometrial cancer, and cardiovascular disease. As a result, the use of Meso-Butestrol and similar compounds has declined in favor of other treatments with a better safety profile.

History and Development[edit]

Meso-Butestrol was developed during the same period as diethylstilbestrol and other synthetic estrogens. It was part of the broader effort to create effective hormone therapies for women experiencing menopausal symptoms and other estrogen-related conditions. However, the discovery of significant health risks associated with these compounds led to a reevaluation of their use in clinical practice.

Current Status[edit]

Today, Meso-Butestrol is not widely used in medical practice due to the availability of safer and more effective alternatives. Research into synthetic estrogens continues, but the focus has shifted towards developing compounds with fewer side effects and lower health risks.

See Also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.